Abstract
We have previously developed a self-deleting avian leukosis and sarcoma virus (ALSV)- based retroviral vector carrying an additional attachment (att) sequence. Resulting proviruses underwent deletion of viral sequences and were flanked either by two LTRs (LTRs proviruses) or by the additional att sequence and the 3′ LTR (att proviruses). Herein, we have tried to increase (1) the self-deleting properties of this vector, either by raising the selection pressure applied on target cells or by optimizing the size of the internal att sequence, (2) the titer of the vector by deleting or inverting some viral sequences. Moreover, a new type of provirus flanked by att sequences at each end was isolated. Finally, under specific conditions, 100% of proviruses had internal sequences deleted, and as many as 92–100% of proviruses were no longer mobilizable by a replication-competent virus. The inactivation procedure achieved here might improve the biosafety of retroviral vectors.
Similar content being viewed by others
References
Clark J, Whitelaw B (2003) A future for transgenic livestock. Nat Rev Genet 4:825–833
Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic M, Boelhauve M, Brem G, Wolf E, Pfeifer A (2003) Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep 4:1054–1060
Pfeifer A (2004) Lentiviral transgenesis. Transgenic Res 13:513–522
Ailles LE, Naldini L (2002) HIV-1-derived lentiviral vectors. Curr Top Microbiol Immunol 261:31–52
Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296:2410–2413
Cavazzana-Calvo M, Thrasher A, Mavilio F (2004) The future of gene therapy. Nature 427:779–781
Sinn PL, Sauter SL, McCray PB Jr (2005) Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12:1089–1098
Hu WS, Pathak VK (2000) Design of retroviral vectors and helper cells for gene therapy. Pharmacol Rev 52:493–511
Xu K, Ma H, McCown TJ, Verma IM, Kafri T (2001) Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 3:97–104
Cockrell AS, Ma H, Fu K, McCown TJ, Kafri T (2006) A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Mol Ther 14:276–284
Loewen N, Poeschla EM (2005) Lentiviral vectors. Adv Biochem Eng Biotechnol 99:169–191
Hughes SH (2004) The RCAS vector system. Folia Biol (Praha) 50:107–119
Ronfort C, Legras C, Verdier G (1997) The use of retroviral vectors for gene transfer into bird embryo. In: Transgenic animals: generation and use. Harwood Academic Publishers GMBH, Switzerland, pp 83–94
Dong B, Silverman RH, Kandel ES (2008) A natural human retrovirus efficiently complements vectors based on murine leukemia virus. PLoS ONE 3:e3144
Cockrell AS, Kafri T (2007) Gene delivery by lentivirus vectors. Mol Biotechnol 36:184–204
Logan AC, Haas DL, Kafri T, Kohn DB (2004) Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol 78:8421–8436
Choulika A, Guyot V, Nicolas JF (1996) Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J Virol 70:1792–1798
Russ AP, Friedel C, Grez M, von Melchner H (1996) Self-deleting retrovirus vectors for gene therapy. J Virol 70:4927–4932
Fernex C, Dubreuil P, Mannoni P, Bagnis C (1997) Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat- driven transcription in human hematopoietic cells. J Virol 71:7533–7540
Julias JG, Hash D, Pathak VK (1995) E-vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol 69:6839–6846
Delviks KA, Hu WS, Pathak VK (1997) Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J Virol 71:6218–6224
Delviks KA, Pathak VK (1999) Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription. J Virol 73:8837–8842
Grunwald T, Pedersen FS, Wagner R, Uberla K (2004) Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation. J Gene Med 6:147–154
Lund AH, Duch M, Lovmand J, Jorgensen P, Pedersen FS (1997) Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol 71:1191–1195
Brown PO (1997) Integration in retroviruses. In: Coffin JM, Hugues SH, Varmus HE (eds) Cold Spring Harbor Laboratory Press, Cold spring Harbor, pp 161–204
Torne-Celer C, Moreau K, Faure C, Chebloune Y, Verdier G, Ronfort C (2008) A novel self-deleting vector carrying an additional sequence recognized by the viral Integrase (IN). Virus Res 135:72–82
Moscovici C, Moscovici MG, Jimenez H, Lai MM, Hayman MJ, Vogt PK (1977) Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95–103
Cosset FL, Legras C, Chebloune Y, Savatier P, Thoraval P, Thomas JL, Samarut J, Nigon VM, Verdier G (1990) A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes. J Virol 64:1070–1078
Frisby DP, Weiss RA, Roussel M, Stehelin D (1979) The distribution of endogenous chicken retrovirus sequences in the DNA of galliform birds does not coincide with avian phylogenetic relationships. Cell 17:623–634
Ronfort C, Chebloune Y, Cosset FL, Faure C, Nigon VM, Verdier G (1995) Structure and expression of endogenous retroviral sequences in the permanent LMH chicken cell line. Poultry Sci 74:127–135
Emerman M, Temin HM (1984) Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:449–467
Emerman M, Temin HM (1986) Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol Cell Biol 6:792–800
Emerman M, Temin HM (1986) Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res 14:9381–9396
Panganiban AT, Talbot KJ (1993) Efficient insertion from an internal long terminal repeat (LTR)-LTR sequence on a reticuloendotheliosis virus vector is imprecise and cell specific. J Virol 67:1564–1571
Panganiban AT, Temin HM (1984) Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell 36:673–679
Ellis J, Bernstein A (1989) Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration. J Virol 63:2844–2846
Lobel LI, Murphy JE, Goff SP (1989) The palindromic LTR–LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol 63:2629–2637
Soriano P, Friedrich G, Lawinger P (1991) Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J Virol 65:2314–2319
Bushman AR, Burnett L, Berg P (1981) The SV40 nucleotide sequence. Appendix A. In: Tooze J (ed) DNA tumor viruses, 2nd edn. Cold Spring Harbor Laboratory, New York, pp 799–841
Valera A, Perales JC, Hatzoglou M, Bosch F (1994) Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther 5:449–456
von Melchner H, Housman DE (1988) The expression of neomycin phosphotransferase in human promyelocytic leukemia cells (HL60) delays their differentiation. Oncogene 2:137–140
Thoraval P, Savatier P, Xiao JH, Mallet F, Samarut J, Verdier G, Nigon V (1987) Partial nucleotide sequence of the avian erythroblastosis virus (AEV ES4). Nucleic Acids Res 15:9612
Acknowledgments
This work was supported by research grants from the Institut National de la Recherche Agronomique (INRA), the Centre National de la Recherche Scientifique (CNRS), and the Association pour la Recherche sur le Cancer (ARC). We thank Transgene SA (Strasbourg), the INRA and the Ligue Nationale Contre le Cancer for fellowships (CTC) and the Ministère de l’Education Nationale et de la Recherche (MENRT) for fellowships (KM). Special thanks to Dr. Antoine Drynda and Dr. Yahia Chebloune for their helpful contributions to this work as well as to Dr. Christophe Terzian for statistical analyses. Thanks are also due to Dr. M. Mehtali (Transgene) and collaborators for fruitful discussions and to the INRA translation service for correction of the English.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Torne-Celer, C., Moreau, K., Faure, C. et al. An improved self-deleting retroviral vector derived from avian leukemia and sarcoma virus. Arch Virol 153, 2233–2243 (2008). https://doi.org/10.1007/s00705-008-0252-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-008-0252-1